Annual Drug Patent Expirations for FORTEO
Forteo is a drug marketed by Lilly and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FORTEO.
This drug has thirty patent family members in twenty-five countries.
The generic ingredient in FORTEO is teriparatide. Two suppliers are listed for this compound. Additional details are available on the teriparatide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
